Scientific Tree invites all the cardiology professionals and people interested in cardiology profession across the nations to submit their Abstracts before the deadline ends. Kindly submit your abstract. There are altogether 19 sessions on cardiology profession. Chose your calling and please submit your abstract relevant to the conference or session.
Heart disease is that when patient experiences chest discomfort, tightness or pain. Heart diseases are many such as coronary artery disease, plaque accumulation (atherosclerosis), blood vessel diseases, heart rhythm problems (arrhythmias); and congenital heart defects rheumatic heart disease, hypertensive heart disease, ischemic heart disease, hypertension and many more. There are number of heart diseases which include blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythmias); and congenital heart defects, rheumatic heart disease, hypertensive heart disease, ischemic heart disease, hypertension etc. Heart failure is a condition in which your heart fails to pump enough blood to meet your body's needs. Heart failure is a serious condition that requires medical care. This session discusses about the causative factors and the latest technological advances made in the treatment of heart diseases
Heart Diseases need to be diagnosed on time. Depending on the condition of your heart, doctors suggest diagnostic tests, which include Electrocardiogram (ECG), Echocardiogram, Holter monitoring, stress test, cardiac catheterization, X-rays, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), and various blood tests, and the family history to check for genetic factors. Based on the findings of these diagnoses, you are advised medical care and treatment procedures. This session discusses the emerging advanced technologies in diagnosing heart patients.
Heart Devices are electronic devices for assisting cardiac circulation, which are used either too partially or to completely replace the function of a failing heart. These devices include cardioverter defibrillators, implantable or ICDs, pacemakers, biventricular pacemaker, implanted heart rhythm monitors called loop recorders, implantable cardioverter defibrillator, a battery-operated left ventricular assist device (LVAD) etc. This session discusses various heart devices and the advanced technologies that make heart devices more heart-friendly.
There is every need to strengthen the cardiac and cardiovascular research to explore more new avenues including the evaluation of current research activities. The Cardiovascular Research needs to focus on cardiovascular disease initiatives, patient care, clinical trials, new tests, treatments, and advancing innovative therapeutics and novel diagnostics to treat and prevent cardiovascular diseases. This session discusses various initiatives, discoveries and the application of latest technologies, new direction to cardiovascular research, the application of latest technologies in research like laser technology, robotics, nanotechnology etc.
Obesity causes diabetes and heart problems increasing the risk for a stroke. Obesity also affects heart and blood vessels. Besides diabetes and heart problems, obesity also causes respiratory problems, abnormal blood cholesterols, gallstones, and osteoarthritis. Obesity is intimately intertwined with multiple health conditions that underlie cardiovascular disease including high blood pressure, and diabetes. Therefore having obesity and diabetes both increases the risk for heart disease and stroke. This session discusses the consequences of diabetes and obesity increasing heart problems, and the latest multi-pronged treatment methodologies to target diabetes, heart problems and obesity etc.
Paediatric Cardiology deals with diseases of heart in children and adolescents. Paediatric Cardiologists treat congenital heart diseases, arrhythmias, variations in heartbeat rhythm, and disturbances in circulatory function. Paediatric Cardiologists also need to be professionally experts in generall paediatrics in order to give better patient care deliveries. Paediatric Cardiologists play a vital role in teaching medical students, doctors, general paediatricians, nurses and paramedical staff to equip them well with excellent patient care deliveries. This session discusses various issues concerning paediatric cardiology including research, diagnosis, treatment interventions, and patient care management.
For the last 150 years or so, investigations are going on intensely on heart regeneration. This is a very challenging proposition since heart is the least regenerative organ in the body, unlike liver, lungs, bladder, bone or skin. So the heart regeneration is possible in the near future in the light of heart problems rising and causing serious health problems causing death. This session discusses if heart regeneration is possible in the near future, and further discusses if human heart has an innate regenerative response, the latest techniques to be adopted in research to find out if heart regeneration is possible.
There have been a number of major advances in pharmacological and mechanical treatments for acute myocardial infarction. This is evident in the fact that large-scale randomized trials of aspirin and β-blockade. Despite this progress, myocardial infarction remains a major global cause of mortality and morbidity, driving a quest for novel treatments in this area. In fact, the last three decades have seen advances in ischemic conditioning, pharmacological and metabolic cardio-protection as well as biological and stem-cell therapies. This session discusses what future cardiology medicines are required including the regenerative therapies, the clinical trials, the advanced research techniques, newer drugs, the development of vaccines, extensive studies in DNA and Genetic Engineering, the role of pharmaceutical companies etc are considered for discussions and debates
Every year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Death rates from both ischaemic heart disease (IHD) and stroke are higher in Central and Eastern Europe.
Over the past 25 years, the absolute number of CVD cases has increased in Europe and in EU with increases in the number of new CVD cases found in most countries.
Hospital discharge rates for CVD as a whole have increased steadily in Europe over the past 25 years. Dietary factors and high systolic blood pressure make the largest contribution to the risk of CVD mortality across Europe. Smoking rates have decreased across much of Europe while is high in Soviet Union countries. Levels of obesity are high across Europe and EU. Overall CVD is estimated to cost the EU economy €210 billion a year. This session discusses various options available to bring down the CVD mortality rate to a tolerable level through educating people around the world about the risk factors that causes CVD and other heart diseases.
Antimicrobial agents are those that destroy diseases and infections caused by different types of
The vascular system defines the body's network of blood vessels, which include the arteries, veins and capillaries that carry blood to and from the heart. Problems of the vascular system are common and can be serious. Thickening of arteries can cause atherosclerosis. Blood clots can clog vessels and block blood flow to the heart or brain. Weakened blood vessels can burst, causing bleeding inside the body. The risk of vascular disease is more as you age along. Other risk factors include are family history, congenital heart problems, illness or injury, obesity, long periods of sitting or standing, high cholesterol levels, smoking alcohol, excessive intake of fat-concentrated foods. This session discusses various issues in how to bring down the mortality rate in cases of cardiovascular heart diseases.
Our current research focuses on the early detection of CHD in order to halt or reverse the progress of the disease. The ongoing research includes advances in medicine, the role of pharmaceutical companies, the discovery of vaccines, new drugs, latest applications in diagnoses of cardiologic problems, scanning, X-ray and other tests, early detection methods, reversing the progress of disease, increasing survival rate etc studies on nuclear cardiology, new techniques in evaluating heart diseases, impact of diet regimen, alcohol and smoking, obesity are need to be discussed threadbare in this session on current research in cardiology.
When heart becomes stretched and weakened and not able to pump effectively, such condition is called dilated cardiomyopathy. If the right side of the heart is affected, heart failure happens when the heart is not able to pump strongly enough to meet the needs of the body. In such a case tissues in the body do not get enough oxygen. If the left side of the heart is affected, it is unable to pump enough blood to the rest of the body. In most cases, heart failure affects both left and right side, but it can occur on just one side. Heart failure in most of the cases becomes life-threatening and no more manageable through with medical therapies. This session discusses about heart failures and cardiomyopathy and finds out how to improvise the life-expectancy of people suffering from several types of heart diseases.
There is a risk of cardiovascular diseases during pregnancy. It is a challenge to treat such patients without affecting the lives of mother and child. Even in normal patients during pregnancy dramatic changes occurring in physiology may affect the cardiovascular system too. These include an increase in plasma volume by 50%, an increase in resting pulse by 17%, and an increase in cardiac output by 50%. After delivery, the heart rate normalizes within 10 days; by 3 months postpartum, stroke volume, cardiac output, and systemic vascular resistance return to the pre-pregnancy state. Cardiologists working in tandem with obstetrics, gynecologists, and pediatrics should provide the best treatment interventions.
Depending on the type of heart diseases, there are several surgeries available to treat heart patients. Medicinal treatments or surgeries depend on the condition and diagnosis of the patient. If you've had a heart attack, you may have already had certain procedures to help you survive your heart attack and diagnose your condition. Surgeries which include are Angioplasty, Laser Artificial Heart Valve Surgery, Atherectomy, Bypass Surgery, Cardiomyoplasty, Thrombolysis Heart Transplant, Coronary Artery Bypass Graft Surgery (CABG), Minimally Invasive Heart Surgery, Radiofrequency Ablation, Stent Placement, and Transmyocardial Revascularization (TMR) and so on. This session discusses various advanced technologies in cardiac surgeries
There are several medications to treat your heart diseases. Such medications may be taken for the rest of your life. Cardiac medications include Anticoagulants, Antiplatelet Agents and Dual Antiplatelet Therapy (DAPT), Angiotensin-Converting Enzyme (ACE) Inhibitors, Combined alpha and beta-blockers, Digitalis Preparations, Beta Blockers, Calcium Channel Blockers, Cholesterol-lowering medications, Angiotensin II Receptor Blockers (or Inhibitors), Angiotensin-Receptor Neprilysin Inhibitors (ARNIs), Vasodilators, Diuretics etc.
Coronary Heart Disease (CHD) is a disease in which a waxy substance called plaque builds up inside the coronary arteries. These arteries supply oxygen-rich blood to your heart muscle. This condition is called Atherosclerosis. Narrowing of coronary arteries that supply oxygen and blood to the heart is known as coronary artery disease. It is a major cause of illness and death. Coronary heart diseases are angina pectoris known as chest pain, shortness of breath, myocardial infarction, or heart attack. This session discusses various options in treatment procedures, diagnosis methodologies, and latest advance technologies in surgery, diet and lifestyle changes in patients.
Molecular Cardiology is the study of genetic heart disorders. The aim of the study on molecular cardiology is to reduce heart diseases in humans through clinical cardiology and laboratory studies on molecular cardiology. The research study includes the studies on basic cellular systems, animal models of human disease, human genes and gene discoveries, exome sequencing, mRNA and microRNA profiling, and RNASeq etc needs to pursue vigorously. This session discusses various aspects in molecular cardiology, the role of DNA, cellular biology, genetic engineering in relation to molecular cardiology etc.
Chronic hypertension, congenital heart disease with intracardiac shunting, decline in left ventricular performance, and valvular heart disease may lead to cardiac remodeling. Ventricular remodeling or cardiac remodeling refers to changes in size, shape, structure, and functioning of the heart. Ventricular remodeling may result in diminished contractile (systolic) function and reduced stroke volume. This occurs after exercises or physiological remodeling or after injury to the heart muscle called pathological remodeling. Physiological remodeling is reversible which means in cardiology, an improvement in ventricular mechanics and functions. Ventricular remodeling includes ventricular dilation, cardiomegaly, cardiomyopathy, ventricular hypertrophy and many other types. This session discusses further improvements in cardiac and ventricular remodeling etc
Acute myocardial infarction is called a heart attack. It is a life-threatening condition that occurs when blood flow to the heart is abruptly cut off, causing tissue damage. This happens when a blockage occurs in one or more coronary arteries. A blockage happens due to a buildup of plaque. A plaque is a substance mostly made of fat, cholesterol, and cellular waste products. The symptoms of myocardial infarction are fatigue, chest discomfort, malaise epigastric, indigestion or of fullness and gas etc.